| Financial Year |
March 31 2023 |
| Monetary Funds |
1,131,784,093.63 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
17,075,168.20 |
| Accounts Receivable |
1,316,832,485.33 |
| Advances to Suppliers |
35,570,474.76 |
| Other Receivables |
20,005,362.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
58,175,385.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
11,461,523.05 |
| Other Current Assets |
169,110,272.02 |
| Total Current Assets |
3,812,812,027.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
438,979,049.12 |
| Investment Properties |
4,020,482.85 |
| Fixed Assetes |
120,401,737.40 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
648,197,418.41 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
582,103.60 |
| Deferred Income Tax Assets |
85,701,909.93 |
| Other Non-Current Assets |
1,204,833.47 |
| Sub-Total of Non-Current Assets |
1,477,895,016.51 |
| Total Assets |
5,290,707,044.40 |
| Short-Term Loans |
585,127,574.10 |
| Trading Financial liabilities |
-- |
| Notes Payable |
109,070,000.00 |
| Accounts Payable |
1,280,106,248.11 |
| Accounts Received In Advance |
246,091.48 |
| Employee Compensation Payable |
9,921,949.71 |
| Taxes Payable |
63,063,575.08 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,767,183.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
81,291,146.70 |
| Other Current Liabilities |
204,692,974.31 |
| Sub-Total of Current Liabilities |
2,755,748,368.47 |
| Long-term Loans |
1,128,865,734.94 |
| Bonds Payable |
299,550,839.28 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
347,215.06 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,430,663,283.84 |
| Total Liabilities |
4,186,411,652.31 |
| Paid-In Capital(Or Share Stock) |
466,660,000.00 |
| Capital Surplus |
277,635,053.74 |
| Surplus Reserve |
17,361,475.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
225,209,409.42 |
| Minority Stockholder's Interest |
54,533,661.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,049,761,730.83 |
| Owner's Equity（Stockholder's Equity） |
1,104,295,392.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,290,707,044.40 |
